We are a pioneering biotech startup, striving to revolutionize healthcare through a focus on multidisciplinary innovations in stem cells and genome editing.

We are committed to ethics, safety, quality and effectiveness, we’re setting new standards in responsible and sustainable scientific advancements that benefit humanity.

Our Vision

To become a global leader in regenerative medicine, delivering science-driven solutions that extend human healthspan, enhance wellness, and redefine preventive healthcare.

Our Values

Science First – We build on evidence, innovation, and rigorous research.

Integrity – Ethical, transparent, and responsible in everything we do.

Sustainability – Committed to environmental and social responsibility.

Human Impact – Improving lives is at the core of our mission.

Our Policies

We are committed to strict compliance with Good Manufacturing Practice (GMP) standards, ethical sourcing of biological materials, and alignment with international regulatory frameworks. As we grow, our Environmental, Social, and Governance (ESG) principles will guide long-term strategy and decision-making.

Team

Lelle Hagström

Chief executive officer (CEO)

Lorena Moreno

Chief reputation officer (CRO)

Salman Shakoh

Dr & MD Western Asia

Sonny Berg

Regional Director of Sales

Nick

Head of IT

Expert Group

Placeholder Name

Placeholder Title & Position

Placeholder Name

Placeholder Title & Position

Placeholder Name

Placeholder Title & Position

Products & Services

Our products

hMSCs

Mesenchymal Stem Cells from Wharton’s Jelly

Mesenchymal Stem Cells are ideal for regenerative medicine research, tissue engineering, inflammation modulation, and more due to their ability to differentiate into various cell types.

Benefits

High viability and purity

Proven regenerative properties

Versatility in research applications

Applications

Tissue engineering

Inflammation modulation

Cellular therapies

Specifications

General

Vial volume2ml
Vial temp-196°C to -80°C
Cell count10M cells/vial
Cell viability>80%

Identification

CD90+99.5%
CD73+99.2%
CD133-0.077%
CD(34+/45-)0.115%

hHSCs

Hematopoietic Stem Cells from Umbilical Cord Blood

These cells are essential for studies in hematopoiesis, immune system research, and gene therapy.

Benefits

High cell count and purity

Essential for hematopoiesis research

Reliable source for immune system studies

Applications

Hematopoiesis research

Immune system studies

Gene therapy

Specifications

General

Vial volume2ml
Vial temp-196°C to -80°C
Cell count10M cells/vial
Cell viability>80%

Identification

CD90+70%
CD73+6.5%
CD105+0.8%
CD(45-/90+)4.55%
CD(45-/90+/73+/105+)0.2%
CD(34+/45+)0.3%

ExoCell

Exosomes from Wharton’s Jelly derived hMSC

ExoCell is isolated from serum-free media of these cells via ultracentrifugation. ExoCell contains a multitude of growth factors that enhance cellular and biochemical events, making it an invaluable tool for regenerative and therapeutic research.

Benefits

Rich in growth factors

Enhances cellular and biochemical events

Ideal for regenerative and therapeutic research

Applications

Regenerative medicine

Therapeutic research

Cellular communication studies

Specifications

TBD

Contact Information

Phone: +46(0)706656400

Mail: info@ixi.ltd

Address:
Novum Labs
Karolinska Institutet
Hälsovägen 7
Huddinge
Sweden
14157

  • Vision & Values & Policies
  • Board & Governance
  • Products & Services

Copyright © 2025